title: Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients.
abstract: To investigate the association between the polymorphisms of human platelet antigen (HPA)-1,2,3,4,5 and susceptibility to develop thrombosis accident in arteriovenous fistula (AVF), genomic DNA of 112 hemodialysis (HD) patients and 100 healthy blood donors were genotyped by PCR-SSP. The patients were classified into 2 groups: G1 included 54 HD patients presented at least one thrombotic episode on the level of the AVF, and G2 included 58 HD patients without any episode of thrombosis. The allelic frequencies of HPA-1, 2, 3, and 5 among patients and controls did not reveal significant differences. However, the HPA-4b allele was significantly more frequent in G1 than in controls or in G2 patients (23.1% vs. 11.5% and 0.9%, respectively), p<0.01 and p<0.001. The genotype distribution of HPA-4 polymorphism reveals that the HPA-4a4b genotype was more frequent in G1 patients (23/54: 42.6%) than in all HD patients (25/112: 22.3%) or in G2 patients (1/58: 1.72%) (p<0.001, odds ratio: 45.6). Among 24 HD patients with HPA-4a4b genotype, 23 (96%) developed at least 1 or more thrombotic episode on the level of their AVF. However, 30 patients (34.5%) among 87 HD patients with HPA-4a4a genotype presented thrombotic episode (p<0.001). These results reveal a significant association between HPA-4a4b and thrombosis, and it is likely that HPA polymorphisms could be useful markers for potential risk of thrombosis in hemodialysis.
authors.affiliation: Laboratory of Immunology, Charles Nicolle Hospital, Tunis, Tunisia. yousr_gorgi@yahoo.fr
authors.forename: Yousr
authors.initials: Y
authors.lastname: Gorgi
authors.forename: Imen
authors.initials: I
authors.lastname: Sfar
authors.forename: Taieb
authors.initials: T
authors.lastname: Ben Aabdallah
authors.forename: Houda
authors.initials: H
authors.lastname: Aouadi
authors.forename: Ezzeddine
authors.initials: E
authors.lastname: Abderrahim
authors.forename: Rafika
authors.initials: R
authors.lastname: Bardi
authors.forename: Saloua
authors.initials: S
authors.lastname: Jendoubi-Ayed
authors.forename: Khaled
authors.initials: K
authors.lastname: Ayed
mesh_terms: D000328:Adult; D016824:Antigens, Human Platelet / Q000235:genetics*; D015415:Biomarkers; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D005838:Genotype; D006083:Graft Occlusion, Vascular / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D006435:Renal Dialysis; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000235:genetics*
chemical_list: C057260:4a alloantigen, human; C510800:4b alloantigen, human; D016824:Antigens, Human Platelet; D015415:Biomarkers